Novaken
Latest round
- Series C
Last raised
- Feb 2025
Total raised
- $16M
Investors
- 4
About Novaken
Established in 2007 and based in Guangzhou, China, Novaken operates as an innovative drug developer that focuses on the development of innovative drug formulations and technology platforms. It acquired certifications such as ISO90001, ISO14001, and ISO45001. The company has obtained more than 100 patents and high-tech enterprise certification. Dr. Chuanbin Wu, the founder of the company, used to hold senior R&D management positions in Johnson & Johnson, Novartis, and Actavis. The company is engaged in the development of innovative drug formulations and technology platforms. It has two new drug technology platforms, which are soluble microneedles and inhalation formulations. Products include Someprazole Magnesium Enteric-coated Tablets, Nifedipine Sustained Release Tablets, Zolpidem Tartrate Sustained Release Tablets, etc. The drugs developed are suitable for eye inflammation, intestinal infection, gastrointestinal ulcers, pancreatic cancer, and other fields. The company generates revenue by providing innovative drug formulations and technology platforms, such as Oxybunium Sustained-Release Tablets, Tacrolimus Granules, and Ribavirin Tablet.
Who invested in Novaken
4 investors across 3 rounds
See all investors in Novaken
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Novaken
Who invested in Novaken?
Novaken has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novaken raised?
Novaken has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Novaken last raise money?
Novaken's most recent round on record is a Series C, in Feb 2025.
What does Novaken do?
Established in 2007 and based in Guangzhou, China, Novaken operates as an innovative drug developer that focuses on the development of innovative drug formulations and technology platforms.
Where is Novaken headquartered?
Novaken is headquartered in Guangzhou, China.
Which VCs invest in companies like Novaken?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Novaken's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Novaken? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.